LataMed AI is trading 5.82% down at $0.33, with the immediate cause uncertain.
- The stock fell 7.79% on September 14 and 10.50% on September 11, extending recent weakness.
- No new company-specific catalyst was identified for September 15; the latest disclosed development remains the September 9 Venezuelan healthcare-technology cooperation agreement, which does not directly explain today’s decline.
- Broader markets are weaker, but healthcare is outperforming.